Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.03 +0.14 (+4.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Research & Development (2015 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) reported Research & Development of $4.49 million for Q2 2026, up 37.2% from $3.27 million a year earlier but down 9.4% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Research & Development (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Insight Molecular Diagnostics' Research & Development came in at $19.15 million, up 69.9% year-over-year; for FY2025, it was $15.9 million, up 61.6% from FY2024.

  • Research & Development has increased for four consecutive years, with a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
  • By year, Research & Development came in at $9.84 million in FY2024 (+5.9%), $9.29 million in FY2023 (+27.3%), $7.3 million in FY2022 (+45.0%) and $5.04 million in FY2021 (-48.6%).
  • Five-year quarterly Research & Development spans a low of $1.38 million in Q4 2022 and a high of $5.83 million in Q4 2025.
  • Year over year, Research & Development has now increased in each of the last six quarters, with growth averaging 47.5% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q4 2025 (growth of 158.3%); the low point was Q4 2022 (a decline of 70.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.95 million (Q1 2026), $5.83 million (Q4 2025) and $3.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn 892.00 Mn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn 370.60 Mn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn 771.00 Mn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn 554.00 Mn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn 258.00 Mn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 278.90 Mn
10 Insight Molecular Diagnostics 111.72 Mn 35.44 Mn 157,000.00 4.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.49 Mn
Mar 31, 2026 4.95 Mn
Dec 31, 2025 5.83 Mn
Sep 30, 2025 3.88 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 2.92 Mn
Dec 31, 2024 2.26 Mn
Sep 30, 2024 2.82 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 2.31 Mn
Dec 31, 2023 2.55 Mn
Sep 30, 2023 2.19 Mn
Jun 30, 2023 2.44 Mn
Mar 31, 2023 2.13 Mn
Dec 31, 2022 1.38 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 2.44 Mn
Mar 31, 2022 2.01 Mn
Dec 31, 2021 4.59 Mn
Sep 30, 2021 3.14 Mn
API Access

Insight Molecular Diagnostics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IMDX&period=max&api_key=YOUR_API_KEY